Key Insights

Highlights

Success Rate

96% trial completion (above average)

Published Results

82 trials with published results (16%)

Research Maturity

302 completed trials (61% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

2.8%

14 terminated out of 499 trials

Success Rate

95.6%

+9.0% vs benchmark

Late-Stage Pipeline

19%

96 trials in Phase 3/4

Results Transparency

27%

82 of 302 completed with results

Key Signals

82 with results96% success14 terminated

Data Visualizations

Phase Distribution

408Total
Not Applicable (258)
Early P 1 (8)
P 1 (20)
P 2 (26)
P 3 (55)
P 4 (41)

Trial Status

Completed302
Recruiting60
Unknown59
Not Yet Recruiting29
Active Not Recruiting17
Terminated14

Trial Success Rate

95.6%

Benchmark: 86.6%

Based on 302 completed trials

Clinical Trials (499)

Showing 20 of 20 trials
NCT07566468RecruitingPrimary

Role of Theta Frequency Oscillations in Proactive and Reactive Control Processes in Youth With Attention Deficit Hyperactivity Disorder (ADHD) and Obsessive Compulsive Disorder (OCD)

NCT07838311Phase 4Not Yet RecruitingPrimary

Delayed-Release, Extended-Release Methylphenidate (Jornay PM) for Adolescents and Young Adults With Attention-Deficit/Hyperactivity Disorder and Cannabis Use Disorder

NCT04504474TerminatedPrimary

Network Analysis of Adult MDD and ADHD

NCT07836244Completed

Predicting the Outcome of ADHD in White Matter Injure Neonates With Multi-modality MRI

NCT07834437Not ApplicableRecruitingPrimary

A Comparison of Group Cognitive Behavioural Therapy (CBT) and Structured Activity Group for Adults With Attention Deficit Hyperactivity Disorder (ADHD)

NCT05842330Phase 3RecruitingPrimary

Benefits of ADHD Treatment in Detained People

NCT07805382Not Yet RecruitingPrimary

Dynamic Relationships Between Estrogen Fluctuations, Sleep, and Psychiatric Complexity Among Adolescent Females With ADHD

NCT07661823Not ApplicableNot Yet Recruiting

QAIAx (AIhealth4U) - AI Smart Health Cities: Microcity Enclave Program (Quantum AI/AGI Agency a/k/a AI City Hall Project - UPSTO App Nos. 64/074,526, 64/063,557, 64/105,164, 63/903,181, 63/729,428, 64/125,360)

NCT04240756Phase 3CompletedPrimary

Treating Parents With ADHD and Their Young Children Via Telehealth: A Hybrid Type I Effectiveness-Implementation Trial

NCT07812987Not ApplicableActive Not Recruiting

Rapid Entrainment and Signal-guided Neuromodulation for Behavioral Health

NCT04526600Not ApplicableRecruitingPrimary

Fidgeting and Attentional and Emotional Regulation in ADHD

NCT07821060Not ApplicableEnrolling By InvitationPrimary

Developing Microbiome and Dietary Strategies Based on Chrono-nutrition for Targeting ADHD

NCT07756255Phase 2Not Yet RecruitingPrimary

A Clinical Trial Evaluating Fecal Microbiota Transplantation (FMT) in Adolescents With ADHD

NCT07812948Not ApplicableNot Yet RecruitingPrimary

Personalising ADHD Medication Treatment for Children and Young People

NCT07812714Not Yet RecruitingPrimary

ADHD and Mental Effort

NCT07773883Phase 3Enrolling By InvitationPrimary

An Open-Label Study to Assess the Long-Term Safety of Solriamfetol in Children and Adolescents With ADHD

NCT07717892Phase 3RecruitingPrimary

Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-3)

NCT06540547Not ApplicableActive Not RecruitingPrimary

Moms Managing Attention-Deficit/Hyperactivity Disorder (ADHD) Study

NCT07717879Phase 3RecruitingPrimary

Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)

NCT07594730Not ApplicableNot Yet Recruiting

Brief Intervention Addressing Stigma Among Parents of Children With Mental Health Problems

Scroll to load more

Research Network

Activity Timeline